Works matching DE "ALISKIREN"

Results: 219

Aliskiren reduces portal pressure in cirrhotic rats.

Published in:

Liver International, 2012, v. 32, n. 4, p. 692, doi. 10.1111/j.1478-3231.2011.02695.x

By:

Chang, Ching-Chih;
Huang, Hui-Chun;
Lee, Wen-Shin;
Wang, Sun-Sang;
Lee, Fa-Yauh;
Lin, Han-Chieh;
Nong, Jing-Yi;
Lee, Shou-Dong

Publication type:

Article

Simultaneous determination of aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide in their triple mixture dosage form by capillary zone electrophoresis.

Published in:

Journal of Separation Science, 2014, v. 37, n. 9/10, p. 1206, doi. 10.1002/jssc.201301140

By:

Salim, Mohamed M.;
Ebeid, Walid M.;
El‐Enany, Nahed;
Belal, Fathalla;
Walash, Mohamed;
Patonay, Gabor

Publication type:

Article

A Total Synthesis of Aliskiren.

Published in:

Helvetica Chimica Acta, 2012, v. 95, n. 10, p. 1937, doi. 10.1002/hlca.201200425

By:

Nam, Gyeok;
Ko, Soo Y.

Publication type:

Article

Amlodipine-Associated Angioedema: An Integrated Pharmacovigilance Assessment Using Disproportionality and Interaction Analysis and Case Reviews.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1097, doi. 10.3390/jcm14041097

By:

Sridharan, Kannan;
Sivaramakrishnan, Gowri

Publication type:

Article

Renin Inhibition with Aliskiren: A Decade of Clinical Experience.

Published in:

Journal of Clinical Medicine, 2017, v. 6, n. 6, p. 61, doi. 10.3390/jcm6060061

By:

Pantzaris, Nikolaos-Dimitrios;
Karanikolas, Evangelos;
Tsiotsios, Konstantinos;
Velissaris, Dimitrios

Publication type:

Article

Heart failure medication treatment and prognosis: a retrospective cross-sectional study.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1532123

By:

Lin, Qiankai;
Lv, Zongjie;
Li, Daiyi;
Ling, Qiao;
Qiu, Sha;
Lei, Xiaomei;
Qin, Fang;
Wang, Na

Publication type:

Article

Aliskiren Improves Ischemia- and Oxygen Glucose Deprivation-Induced Cardiac Injury through Activation of Autophagy and AMP-Activated Protein Kinase.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00819

By:

Ming-Hsien Chiang;
Chan-Jung Liang;
Chen-Wei Liu;
Bo-Jhih Pan;
Wen-Ping Chen;
Yi-Fan Yang;
I-Ta Lee;
Jaw-Shiun Tsai;
Chiang-Wen Lee;
Yuh-Lien Chen

Publication type:

Article

The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through 'stacking' of drugs from different classes.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2046, doi. 10.1111/dom.15559

By:

Bell, David S. H.;
Jerkins, Terri

Publication type:

Article

N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) predicts the cardio‐renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.

Published in:

Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2899, doi. 10.1111/dom.13465

By:

Idzerda, Nienke M. A.;
Persson, Frederik;
Pena, Michelle J.;
Brenner, Barry M.;
Brunel, Patrick;
Chaturvedi, Nish;
McMurray, John J.;
Parving, Hans‐Henrik;
de Zeeuw, Dick;
Heerspink, Hiddo J. L.

Publication type:

Article

Direct renin inhibition improves parasympathetic function in diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2013, v. 15, n. 1, p. 28, doi. 10.1111/j.1463-1326.2012.01669.x

By:

Maser, R. E.;
Lenhard, M. J.;
Kolm, P.;
Edwards, D. G.

Publication type:

Article

Profibrosing Effect of Angiotensin Converting Enzyme Inhibitors in Human Lung Fibroblasts.

Published in:

2015

By:

Díaz-Piña, Gabriela;
Montes, Eduardo;
Checa, Marco;
Becerril, Carina;
García de Alba, Carolina;
Vega, Anita;
Páramo, Ignacio;
Ordoñez-Razo, Rosa;
Ruiz, Victor

Publication type:

Report

Comparative evaluation of aliskiren, ramipril, and losartan on psychomotor performance in healthy volunteers: A preliminary report.

Published in:

Perspectives in Clinical Research, 2014, v. 5, n. 4, p. 190, doi. 10.4103/2229-3485.140564

By:

Arora, Ekta;
Khajuria, Vijay;
Tandon, Vishal R.;
Sharma, Atul;
Choudhary, Naiyma

Publication type:

Article

Aliskiren has chondroprotective efficacy in a rat model of osteoarthritis through suppression of the local renin‑angiotensin system.

Published in:

Molecular Medicine Reports, 2017, v. 16, n. 4, p. 3965, doi. 10.3892/mmr.2017.7110

By:

KAIZHONG YAN;
YIXIN SHEN

Publication type:

Article

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome.

Published in:

Diabetology & Metabolic Syndrome, 2017, v. 9, p. 1, doi. 10.1186/s13098-017-0282-5

By:

Ramalho, F. N.;
Sanches, S. C.;
Foss, M. C.;
Augusto, M. J.;
Silva, D. M.;
Oliveira, A. M.;
Ramalho, L. N.

Publication type:

Article

Aliskiren, Fosinopril, and Their Outcome on Renin-Angiotensin-Aldosterone System (RAAS) in Rats with Thyroid Dysfunction.

Published in:

International Journal of Endocrinology, 2019, p. 1, doi. 10.1155/2019/5960563

By:

Farhadi, Susan A. S.;
Dizaye, Kawa F.

Publication type:

Article

Combination Angiotensin Converting Enzyme and Direct Renin Inhibition in Heart Failure following Experimental Myocardial Infarction.

Published in:

Cardiovascular Therapeutics, 2013, v. 31, n. 2, p. 84, doi. 10.1111/j.1755-5922.2011.00292.x

By:

Connelly, K.A.;
Advani, A.;
Advani, S.;
Zhang, Y.;
Thai, K.;
Thomas, S.;
Krum, H.;
Kelly, D.J.;
Gilbert, R.E.

Publication type:

Article

Social determinants of patiromer adherence and abandonment: An observational, retrospective, real-world claims analysis.

Published in:

PLoS ONE, 2023, v. 18, n. 3, p. 1, doi. 10.1371/journal.pone.0281775

By:

Kleinman, Nathan;
Kammerer, Jennifer;
LaGuerre, Kevin;
Thakar, Charuhas V.

Publication type:

Article

Time until onset of acute kidney injury by combination therapy with "Triple Whammy" drugs obtained from Japanese Adverse Drug Event Report database.

Published in:

PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0263682

By:

Kunitsu, Yuki;
Hira, Daiki;
Morikochi, Aya;
Ueda, Tomohiro;
Isono, Tetsuichiro;
Morita, Shin-ya;
Terada, Tomohiro

Publication type:

Article

HPTLC Method for Simultaneous Estimation of Aliskiren, Amlodipine, and Hydrochlorothiazide in Synthetic Mixture Using Quality by Design Approach.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2015, v. 38, n. 16, p. 1546, doi. 10.1080/10826076.2015.1076461

By:

Patel, Tushar R.;
Patel, Tejas B.;
Suhagia, Bhanubhai N.;
Shah, Shailesh A.

Publication type:

Article

Aliskiren limits abdominal aortic aneurysm, ventricular hypertrophy and atherosclerosis in an apolipoprotein-E-deficient mouse model.

Published in:

Clinical Science, 2014, v. 127, n. 2, p. 123, doi. 10.1042/CS20130382

By:

Sai-Wang SETO;
KRISHNA, Smriti M.;
MORAN, Corey S.;
LIU, David;
GOLLEDGE, Jonathan

Publication type:

Article

The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.

Published in:

Clinical Science, 2013, v. 125, n. 4, p. 183, doi. 10.1042/CS20120395

By:

SAVOIA, Carmine;
ARRABITO, Emanuele;
PARENTE, Rosa;
SADA, Lidia;
MADARO, Luca;
NICOLETTI, Carmine;
ZEZZA, Luigi;
ALONZO, Alessandro;
RUBATTU, Speranza;
MICHELINI, Serena;
MULLER, Dominik N.;
VOLPE, Massimo

Publication type:

Article

Renin inhibition in the treatment of diabetic kidney disease.

Published in:

Clinical Science, 2013, v. 124, n. 9, p. 553, doi. 10.1042/CS20120468

By:

KOMERS, Radko

Publication type:

Article

41st Rostock Seminar on Cardiovascular Function and Hypertension, Rostock, Germany, June 9, 2012.

Published in:

2013

By:

Eckermann, Peter;
Hausberg, Martin;
Kisters, Klaus;
Noack, Thomas;
Zidek, Walter

Publication type:

Proceeding

About the effects of allsklren on an Isolated heart.

Published in:

2012

By:

Tscherpel, C.;
Hopp, H.-H.;
Kisters, K.;
Noack, T.

Publication type:

Conference Paper/Materials

Effect of combination of renin inhibitor and Mas-receptor agonist in DOCA-salt-induced hypertension in rats.

Published in:

Molecular & Cellular Biochemistry, 2013, v. 373, n. 1/2, p. 189, doi. 10.1007/s11010-012-1489-2

By:

Singh, Yogendra;
Singh, Kulwinder;
Sharma, P.

Publication type:

Article

Intestinal OATP1A2 inhibition as a potential mechanism for the effect of grapefruit juice on aliskiren pharmacokinetics in healthy subjects.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 697, doi. 10.1007/s00228-011-1167-4

By:

Rebello, Sam;
Zhao, Sally;
Hariry, Sam;
Dahlke, Marion;
Alexander, Natalya;
Vapurcuyan, Arpine;
Hanna, Imad;
Jarugula, Venkateswar

Publication type:

Article

Hypertension.

Published in:: Nephrology Dialysis Transplantation, 2012, v. 27, n. suppl_2, p. ii26, doi. 10.1093/ndt/gfs188
Publication type:: Article

Renoprotective effect of aliskiren on renal ischemia/reperfusion injury in rats: electron microscopy and molecular study.

Published in:

Renal Failure, 2015, v. 37, n. 2, p. 343, doi. 10.3109/0886022X.2014.991327

By:

Ziypak, Tevfik;
Halici, Zekai;
Alkan, Erdal;
Akpinar, Erol;
Polat, Beyzagul;
Adanur, Senol;
Cadirci, Elif;
Ferah, Irmak;
Bayir, Yasin;
Karakus, Emre;
Mercantepe, Tolga

Publication type:

Article

Efficacy of Aliskiren in Japanese Chronic Kidney Disease Patients with Hypertension.

Published in:

Renal Failure, 2012, v. 34, n. 4, p. 442, doi. 10.3109/0886022X.2011.649672

By:

Sakai, Yukinao;
Otsuka, Tomoyuki;
Ohno, Dai;
Murasawa, Tsuneo;
Sato, Naoki;
Mizuno, Kyoichi

Publication type:

Article

Aliskiren单用及联用氟伐他汀对动脉粥样硬化斑块稳定性的影响.

Published in:

Progress in Modern Biomedicine, 2019, v. 19, n. 12, p. 2201, doi. 10.13241/j.cnki.pmb.2019.12.001

By:

吴宏宪;
成宪武;
马元吉;
Toyoaki, Murohara;
钱菊英;
葛均波

Publication type:

Article

Aliskiren reduces the release of soluble (pro)renin receptor from human umbilical vein endothelial cells.

Published in:

Biomedical Reports, 2018, v. 9, n. 3, p. 247, doi. 10.3892/br.2018.1124

By:

Yamashita, Shinji;
Biswas, Kazal Boron;
Nabi, A.H.M. Nurun;
Nakagawa, Tsutomu;
Suzuki, Fumiaki;
Ebihara, Akio

Publication type:

Article

Aliskiren attenuates proteinuria in mice with lupus nephritis by a blood pressure-independent mechanism.

Published in:

Lupus, 2013, v. 22, n. 2, p. 180, doi. 10.1177/0961203312471871

By:

Yen, T-H;
Yang, H-Y;
Yeh, Y-H;
Chu, P-H;
Wen, C-J;
Fu, J-F;
Wang, I-K;
Liang, C-C;
Chang, C-T;
Chen, K-H;
Tian, Y-C;
Hung, C-C;
Lin, J-L;
Yang, C-W

Publication type:

Article

Chiral Organophosphorus Pharmaceuticals: Properties and Application.

Published in:

Symmetry (20738994), 2023, v. 15, n. 8, p. 1550, doi. 10.3390/sym15081550

By:

Kolodiazhna, Anastasy O.;
Kolodiazhnyi, Oleg I.

Publication type:

Article

Niclosamide from an anthelmintic drug to a promising adjuvant therapy for diabetic kidney disease: randomized clinical trial.

Published in:

Diabetology & Metabolic Syndrome, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13098-023-00995-1

By:

El-fatatry, Basma Mahrous;
El-Haggar, Sahar Mohamed;
Ibrahim, Osama Mohamed;
Shalaby, Khaled Hamed

Publication type:

Article

Aliskiren suppresses the renin-angiotensin-aldosterone system and reduces blood pressure and albuminuria in elderly chronic kidney disease patients with hypertension.

Published in:

International Journal of Nephrology & Renovascular Disease, 2012, v. 5, p. 125, doi. 10.2147/IJNRD.S36451

By:

Morishita, Yoshiyuki;
Yasui, Toshihiro;
Numata, Akihiko;
Onishi, Akira;
Ishibashi, Kenichi;
Kusano, Eiji

Publication type:

Article

Long-term effects of aliskiren on blood pressure and the renin-angiotensin-aldosterone system in hypertensive hemodialysis patients.

Published in:

International Journal of Nephrology & Renovascular Disease, 2012, v. 5, p. 45, doi. 10.2147/IJNRD.S30203

By:

Morishita, Yoshiyuki;
Watanabe, Minami;
Hanawa, Shiho;
Iimura, Osamu;
Tsunematsu, Sadao;
Ishibashi, Kenichi;
Kusano, Eiji

Publication type:

Article

Royal Jelly and Aliskiren mutually annul their protective effects against gentamicin-induced nephrotoxicity in rats.

Published in:

Veterinary World, 2020, v. 13, n. 12, p. 2658, doi. 10.14202/vetworld.2020.2658-2662

By:

Alaraj, Mohd

Publication type:

Article

New drugs and dosage forms.

Published in:: American Journal of Health-System Pharmacy, 2018, v. 75, n. 1, p. e2, doi. 10.2146/news180001
Publication type:: Article

Probable drug-induced liver injury associated with aliskiren: Case report and review of adverse event reports from pharmacovigilance databases.

Published in:

American Journal of Health-System Pharmacy, 2014, v. 71, n. 8, p. 643, doi. 10.2146/ajhp130149

By:

CREPIN, SABRINA;
GODET, BERTRAND;
CARRIER, PAUL;
VILLENEUVE, CLAIRE;
MERLE, LOUIS;
LAROCHE, MARIE-LAURE

Publication type:

Article

An Observational, Prospective, Open-Label, Multicentre Evaluation of Aliskiren in Treated, Uncontrolled Patients: A Real-Life, Long-Term, Follow-Up, Clinical Practice in Italy.

Published in:

High Blood Pressure & Cardiovascular Prevention, 2012, v. 19, n. 2, p. 73, doi. 10.2165/11632170-000000000-00000

By:

Tocci, Giuliano;
Aimo, Gianpiero;
Caputo, Dario;
De Matteis, Carmine;
Di Napoli, Tommaso;
Granatelli, Antonino;
Lentini, Pietro;
Magagna, Armando;
Matarrese, Alfonso A.;
Perona, Davide;
Villa, Giuseppe;
Volpe, Massimo

Publication type:

Article

Selected Abstracts from the National Congress of the Italian Society of Hypertension (SIIA 2011).

Published in:: 2011
Publication type:: Abstract

Direct Renin Inhibition: From Pharmacological Innovation to Novel Therapeutic Opportunities.

Published in:

High Blood Pressure & Cardiovascular Prevention, 2011, v. 18, n. 3, p. 93, doi. 10.2165/11593540-000000000-00000

By:

Volpe, Massimo;
Pontremoli, Roberto;
Borghi, Claudio

Publication type:

Article

Aliskiren, the first direct renin inhibitor for treatment of hypertension: The path of its development.

Published in:

Journal of Postgraduate Medicine, 2012, v. 58, n. 1, p. 32, doi. 10.4103/0022-3859.93250

By:

Jadhav, M.;
Yeola, C.;
Zope, G.;
Nabar, A.

Publication type:

Article

A Fully Automated Online SPE-LC-MS/MS Method for the Determination of 10 Pharmaceuticals in Wastewater Samples.

Published in:

Toxics, 2022, v. 10, n. 3, p. 103, doi. 10.3390/toxics10030103

By:

Belay, Masho Hilawie;
Precht, Ulrich;
Mortensen, Peter;
Marengo, Emilio;
Robotti, Elisa

Publication type:

Article

Simultaneous determination of aliskiren, amlodipine and hydrochlorothiazide in spiked human plasma and urine by high performance liquid chromatography.

Published in:

Journal of Analytical Chemistry, 2015, v. 70, n. 4, p. 502, doi. 10.1134/S1061934815040176

By:

Aydoǧmuş, Zeynep

Publication type:

Article

Vitamin D Regulates the Expressions of AQP-1 and AQP-4 in Mice Kidneys.

Published in:

BioMed Research International, 2019, p. 1, doi. 10.1155/2019/3027036

By:

Fu, Yu;
Zhu, Jiajun;
Zhang, Yalin;
Liu, Zuwang;
Su, Han;
Kong, Juan

Publication type:

Article

METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ALISKIREN AND ENALAPRIL IN BULK AND SYNTHETIC MIXTURE BY REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD.

Published in:

Pharmacophore, 2014, v. 5, n. 2, p. 239, doi. 10.51847/zfxpo4s

By:

Sharma, Ishan R.;
Shah, Jignesh S.;
Maheswari, Dilip G.

Publication type:

Article

A REVIEW ON ANALYTICAL METHODS FOR INDIVIDUAL AND SIMULTANEOUS ANALYSIS OF ALISKIREN AND VALSARTAN.

Published in:

Pharma Science Monitor, 2023, v. 14, n. 2, p. 23

By:

Patel, Darshna;
Surati, Jasmina;
Akabari, Ashok;
Patel, Sagar;
Shah, Ketan;
Solanki, Divya

Publication type:

Article

Aliskiren Administration during Early Postnatal Life Sex-Specifically Alleviates Hypertension Programmed by Maternal High Fructose Consumption.

Published in:

Frontiers in Physiology, 2016, p. 1, doi. 10.3389/fphys.2016.00299

By:

Chien-Ning Hsu;
Wu, Kay L. H.;
Wei-Chia Lee;
Leu, Steve;
Chan, Julie Y. H.;
You-Lin Tain

Publication type:

Article

Intracellular renin disrupts chemical communication between heart cells. Pathophysiological implications.

Published in:

Frontiers in Endocrinology, 2015, v. 5, p. 1, doi. 10.3389/fendo.2014.00238

By:

De Mello, Walmor C.

Publication type:

Article